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Frontiers in Neuroscience

The central nervous system (CNS) exerts a strong regulatory influence over
the cardiovascular system in response to environmental demands. FloatationREST (Reduced Environmental Stimulation Therapy) is an intervention that
minimizes stimulation from the environment, yet little is known about the
autonomic consequences of reducing external sensory input to the CNS.
We recently found that Floatation-REST induces a strong anxiolytic effect in
anxious patients while paradoxically enhancing their interoceptive awareness
for cardiorespiratory sensations. To further investigate the physiologic nature
of this anxiolytic effect, the present study measured acute cardiovascular
changes during Floatation-REST using wireless and waterproof equipment
that allowed for concurrent measurement of heart rate, heart rate variability
(HRV), breathing rate, and blood pressure. Using a within-subjects crossover
design, 37 clinically anxious participants with high levels of anxiety sensitivity
and 20 non-anxious comparison participants were randomly assigned to
undergo a 90-min session of either Floatation-REST or an exteroceptive
comparison condition that entailed watching a relaxing nature film. Measures
of state anxiety and serenity were collected before and after each session,
while indices of autonomic activity were measured throughout each session.
HRV was calculated using both time-series and frequency domain analyses.
Linear mixed-effects modeling revealed a significant main effect of condition
such that relative to the film condition, Floatation-REST elicited significant
decreases (p < 0.001) in diastolic blood pressure, systolic blood pressure,
breathing rate, and certain metrics of HRV including the standard deviation
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of the interbeat interval (SDNN), low-frequency HRV, and very low-frequency
HRV. Heart rate showed a non-significant trend (p = 0.073) toward being
lower in the float condition, especially toward the beginning of the session.
The only metric that showed a significant increase during Floatation-REST
was normalized high-frequency HRV (p < 0.001). The observed physiological
changes were consistent across both anxious and non-anxious participants,
and there were no significant group by condition interactions. Blood
pressure was the only cardiac metric significantly associated with float-related
reductions in state anxiety and increases in serenity. These findings suggest
that Floatation-REST lowers sympathetic arousal and alters the balance of the
autonomic nervous system toward a more parasympathetic state.
Clinical trial registration: [https://clinicaltrials.gov/show/NCT03051074],
identifier [NCT03051074].
KEYWORDS

anxiety, interoception, autonomic, heart rate variability, blood pressure

Introduction

during the actual float session, with diastolic blood pressure
showing the largest decrease when compared to watching a
nature documentary (Feinstein et al., 2018b) or lying supine
in a zero-gravity chair (Khalsa et al., 2020). Two previous
studies explored the effects of Floatation-REST on heart rate
(Forgays and Belinson, 1986; O’Leary and Heilbronner, 1990)
with variable results. Forgays and Belinson (1986) recorded
heart rate before, during, and after Floatation-REST over
the course of three sessions and found that heart rate was
highest before floating, steadily fell during the float, and then
rebounded toward the end of the float session. The study,
however, was limited by the lack of a control condition.
O’Leary and Heilbronner (1990) included a supine control
condition that entailed lying on a cot and measured changes
in heart rate and blood pressure using a pre/post design,
and found that Floatation-REST significantly decreased both
metrics as compared to the control condition. Heart rate and
blood pressure are key variables reflecting the operation of the
autonomic nervous system (ANS). Breathing rate and heart
rate variability (HRV) – i.e., the fluctuation in time between
heartbeats – have also emerged as important variables to assess
ANS function (Shaffer and Ginsberg, 2017; Nakao, 2019). Many
mental health conditions appear to have an altered pattern
of HRV, including major depression (Rottenberg, 2007; Kemp
et al., 2010) and anxiety (Chalmers et al., 2014), with patients
often showing significantly lower time domain measurements
of HRV as well as decreased high-frequency HRV. Yet, to date
there has been no research measuring breathing rate or HRV
during Floatation-REST.
A core goal of the current study is to understand how the
ANS responds when the CNS is exposed to an environment
with minimal exteroceptive stimulation and metabolic demand.
This window into ANS functioning in the absence of sensory
stimulation could provide a novel paradigm for measuring an

Floatation-REST (Reduced Environmental Stimulation
Therapy) reduces sensory input to the nervous system through
the act of floating supine in a pool of water supersaturated
with magnesium sulfate (Epsom salt). The float experience is
calibrated so that visual and auditory stimulation is minimized,
the temperature of the air and water is thermoneutral (i.e.,
matched to skin temperature), and the proprioceptive effects
of gravity on muscle tension are significantly attenuated by
the saltwater (which is calibrated to a specific gravity of 1.25
to allow for effortless floating, where approximately half of the
body is floating above the surface of the water and the other half
is submerged under the water). Floatation-REST was developed
by Dr. John C. Lilly and Glenn Perry in the early 1970’s as a
substitute for whole-body water immersion, a technique that
was first used by Dr. Lilly and Dr. Jay Shurley in the 1950’s as a
way to explore how the central nervous system might respond
to an environment devoid of external sensory input (Shurley,
1960; Lilly, 1977). By the late 1970’s, several researchers began
exploring Floatation-REST’s physiological and psychological
effects (Fine and Turner, 1982; Suedfeld et al., 1983), and a
meta-analysis of 27 studies published between 1983 and 2002
found large effect sizes across a population of mostly healthy
subjects, including beneficial changes in physiological variables
(e.g., lower blood pressure and cortisol) and increased levels
of relaxation and subjective well-being (Van Dierendonck and
Nijenhuis, 2005).
Specifically related to cardiovascular changes that occur as
the result of Floatation-REST, several studies have reported
significant reductions in both systolic and diastolic blood
pressure when comparing measurements taken before and after
a float session (Jacobs et al., 1984; Turner et al., 1989). More
recently, our lab has found significant blood pressure reductions
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the baseline physiology in an environment with relatively
neutral audiovisual stimulation. Thus, a within-subjects design
was chosen to allow for the direct comparison of baseline
cardiovascular functioning while one is in a stimulated versus
unstimulated environment. All participants completed both
conditions in a randomized order with approximately 1 week in
between the float and film session. In addition, all participants
floated one time prior to this experiment in order to acclimate
them to the float environment. The participants were comprised
of clinically anxious patients with high levels of anxiety
sensitivity, most of whom were part of a prior study that only
reported blood pressure changes (Feinstein et al., 2018b). We
also recruited a smaller sample of demographically matched
non-anxious comparison participants to explore whether they
showed any notable differences in their physiological response.
Since this was the first Floatation-REST study to concurrently
measure heart rate, HRV, breathing rate, and blood pressure
during the float experience, the analysis is largely exploratory
in nature. Based on the relatively small body of prior research
investigating physiological changes during Floatation-REST,
we hypothesized that floating relative to the film condition
would shift the balance in ANS functioning toward a state of
physiological relaxation characterized by significant decreases
in blood pressure, heart rate, and breathing rate, along
with significant increases in HRV parameters related to the
engagement of the parasympathetic nervous system including
high-frequency HRV. We also predicted that the cardiovascular
changes induced by Floatation-REST would be related to greater
levels of serenity and lower levels of anxiety, helping to parse the
physiological mechanisms by which floating exerts its anxiolytic
effect.

individual’s true physiologic baseline, one that is untethered
from the influences of the external world. However, the baseline
state engendered by floating is not affectively neutral, as prior
research has shown that the float experience induces a state
of serenity and decreased anxiety, effects that were most
pronounced in clinically anxious patients (Feinstein et al.,
2018a,b; Khalsa et al., 2020). Notably, all of the patients
had high levels of anxiety sensitivity, which refers to one’s
fear of experiencing anxiety-related symptoms and sensations,
especially those arising from within the body (Taylor, 2014).
Interestingly, the float environment was found to enhance
awareness for interoceptive sensation, especially sensations
emanating from the cardiorespiratory system (Feinstein et al.,
2018b; Khalsa et al., 2020). This presents a paradox, as one
might expect individuals with high anxiety sensitivity to find
the conscious experience of cardiorespiratory sensations to be
anxiety inducing (rather than reducing). This in turn raises the
intriguing question as to how patients with high levels of anxiety
sensitivity find serenity in an environment which amplifies
awareness for the very sensations most commonly linked to the
experience of anxiety.
A deeper understanding of the neurophysiological processes
underpinning floating’s anxiolytic effect could have important
clinical implications. In a prior study (Feinstein et al., 2018b), we
theorized that the float environment may weaken the aversive
association between visceral sensations and anxiety through a
process of reciprocal inhibition (Wolpe, 1958), culminating in
the formation of a new association, one that links the experience
of cardiorespiratory sensations to a state of relaxation instead
of anxiety. Unfortunately, very little is known about the
physiological correlates of a float-induced state of relaxation.
From a neural perspective, we have shown that Floatation-REST
leads to decreased functional connectivity between the posterior
insula, somatosensory cortices, and the default-mode network,
with greater reductions in connectivity associated with higher
levels of post-float serenity (Al Zoubi et al., 2021). However,
from a cardiovascular perspective, there has not yet been any
float studies linking the physiological response to subjective
changes in anxiety and serenity.
The present study aims to add to this prior research by
more thoroughly characterizing the cardiovascular changes
induced by Floatation-REST and exploring whether any of
the physiological changes are associated with its anxiolytic
effect. Wireless and waterproof equipment was employed to
measure heart rate, HRV, breathing rate, and blood pressure
during a 90-min session of Floatation-REST, as well as
during an exteroceptive comparison condition that entailed
watching a relaxing nature film for an equivalent amount
of time. Both conditions can be conceptualized as capturing
an extended baseline state of cardiovascular functioning
during which participants remained still, without movement
or speech, over a 90-min period of time. Whereas the float
condition measures the baseline physiology in an environment
lacking exteroceptive stimulation, the film condition measures

Frontiers in Neuroscience

Materials and methods
All study procedures were approved by the Western
Institutional Review Board, and all participants provided written
informed consent prior to participation. The trial was registered
on ClinicalTrials.gov, and this study was part of a larger project
examining the subjective, physiological, and neural effects of
Floatation-REST.

Sample characteristics
There were 37 anxious participants who met inclusion
and exclusion criteria and underwent the float and the film
conditions (Supplementary Figure 3 and Supplementary
Table 1). All anxious participants met criteria for one or more
anxiety disorders, spanning the spectrum of different anxiety
and stress-related conditions, with a mix of comorbidities,
including generalized anxiety disorder (n = 20), social anxiety
disorder (n = 13), panic disorder (n = 11), agoraphobia
(n = 8), and posttraumatic stress disorder (n = 13). Most of
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TABLE 1 Participant demographics and baseline functioning.

Anxious
participants
Sample size
Age
Sex, male/female
Medicated participants

Non-anxious
participants

37

20

37.0 (11.4)

37.4 (11.3)

14/23

7/13

23

0

29.0 (11.8)

5.8 (3.7)

Anxiety severity (OASIS)

9.8 (3.8)

1.6 (2.0)

Depression severity (PHQ-9)

11.9 (5.6)

2.5 (3.0)

Level of disability (SDS)

14.1 (7.9)

1.5 (3.0)

Anxiety sensitivity (ASI-3)

Laureate Institute for Brain Research (LIBR). The T1000 is
a naturalistic study that aims to recruit and longitudinally
follow ∼1,000 treatment-seeking individuals from the local
community, many of whom have anxiety and/or depression
(Victor et al., 2018). Each participant received the MiniInternational Neuropsychiatric Interview (MINI) version 6.0,
and all psychiatric diagnoses were confirmed following review
of the clinical history by a board-certified psychiatrist.
The
specific
inclusion
and
exclusion
criteria
(Supplementary Table 1) for recruiting anxious participants
from the T1000 database into the initial float study targeted
individuals with very high levels of anxiety sensitivity (defined
as an ASI-3 total score ≥ 30) across the spectrum of different
anxiety and stress-related disorders, many with comorbid
unipolar depression. Participants were invited back to
participate in the current study so long as they continued
to present with at least a moderate degree of anxiety severity
during the initial float study, defined as an OASIS score ≥ 6. All
clinical self-report measures were re-administered at the start
of this study, and the updated scores are presented in Table 1.
Since the T1000 is a naturalistic study based on a community
sample, we allowed participants who were stably medicated
into the study. However, we added exclusion criteria for more
severe forms of psychopathology and substance use in order to
minimize potential safety risks.

The total or average scores are presented for each metric. Numbers inside parentheses
represent the standard deviation. ASI-3, Anxiety Sensitivity Index-3; OASIS, Overall
Anxiety Severity and Impairment Scale; PHQ-9, Patient Health Questionnaire nine-item
depression scale; SDS, Sheehan Disability Scale.

the anxious participants also had comorbid major depressive
disorder (n = 35). Table 1 provides additional details about
subject demographics and baseline level of functioning. Two
thirds of the participants (n = 23) were stably medicated (for
6 weeks or longer) on one or more psychotropic medications.
Medication-related effects were mitigated by excluding subjects
who recently began taking a new medication and by using a
within-subjects design where every subject served as their own
control. At the start of this study, the anxious participants
were all acutely anxious and depressed, with average group
scores well above the clinical range of severity (Overall Anxiety
Severity and Impairment Scale (OASIS) score = 9.8; Patient
Health Questionnaire nine-item depression scale score (PHQ9) = 11.9). The anxious sample had high levels of anxiety
sensitivity [average Anxiety Sensitivity Index-3 (ASI-3) total
score = 29.0] as well as marked impairment in social and
occupational functioning (average total disability score on the
Sheehan Disability Scale = 14.1). We also recruited 20 nonanxious comparison participants (Supplementary Figure 4 and
Supplementary Table 2) who were demographically matched
to the anxious sample (Table 1). These participants had no
history of any neurological or psychiatric illness and were not
on any psychotropic medications. At the start of this study, the
comparison participants were not acutely anxious or depressed
(average OASIS score = 1.6; average PHQ-9 score = 2.5)
and had low levels of anxiety sensitivity (average ASI-3 total
score = 5.8).

Study design
The protocol entailed a randomized controlled trial using
a within-subjects crossover design. Participants were randomly
assigned to complete a 90-min session of Floatation-REST
(referred to as the float condition) or a 90-min session of an
exteroceptive comparison condition (referred to as the film
condition) that entailed watching a nature documentary from
the BBC Planet Earth series (Attenborough and Fothergill,
2006). After completion of one condition, participants crossed
over to the other condition approximately 1 week later (average
time between conditions was 8 days), with both conditions
scheduled to occur at the same time of day for each participant.
The randomization sequence was predetermined using a 1:1
allocation ratio, and the study used an open-label design with
no blinding or concealed allocation. Self-report measurements
were recorded on a computerized tablet before and after each
condition. Wireless and waterproofed physiological sensors
were attached to the participant prior to the start of each float
and film session (Figure 1).

Participant recruitment
Participants were recruited from a prior study (Feinstein
et al., 2018a) where they underwent a single 60-min float session
(without any physiological measurements) to help acclimate
them to the float environment. On average, there was a 2month gap between completing the previous study and the
current study. In the previous study, participants were recruited
through the Tulsa 1000 (T1000) database maintained at the

Frontiers in Neuroscience

Floatation-REST condition
All float sessions occurred in an open circular fiberglass pool
custom-designed for research purposes by Floataway (Norfolk,
United Kingdom). The open circular float pool was 8 feet
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in diameter and contained 11 inches of water saturated with
∼1,800 pounds of USP grade Epsom salt (magnesium sulfate),
creating a dense saltwater solution maintained at a specific
gravity of ∼1.25, allowing participants to effortlessly float
on their back. Since the pool had no enclosure, participants
could freely enter and exit at any time. The room around the
pool was constructed to be waterproof, soundproof, lightproof,
and temperature-controlled (described in greater detail below).
Silent heaters were placed under the pool to maintain the
water at a constant temperature and a dedicated heating,
ventilation, and air conditioning system maintained the air at
a constant temperature. The temperature of the water and air
approximated the surface temperature of the skin (∼95.0◦ F) and
could be adjusted remotely by the experimenter in a nearby
control room. An intercom system allowed the participant to
freely communicate with the experimenter throughout the float
session should any issues arise, and specialized speakers placed
around the perimeter of the pool allowed the experimenter to
communicate with the participant and play music to signal the
end of the session. While floating, a blue LED light remains
illuminated in the background and could be turned off by the
participant using an air switch. Once triggered, the air switch
activates an infrared wave detection system so that participants
can turn the blue light on and off simply by waving their arm
in the air while floating. The infrared wave detection system was
linked to a digital clock, allowing for the automated calculation
of the total amount of time that a participant was floating with
the lights completely off.
The float pool and surrounding room were specially
engineered to minimize all sensory signals from visual, auditory,
olfactory, gustatory, thermal, tactile, vestibular, gravitational and
proprioceptive channels. Visual stimulation was minimized by
building an entry door and gasket system which expunged all
sources of outside light. In addition, there were no windows
inside the float room, and the adjacent room contained a private
bathroom that also had no windows, and no lights (which were
automatically shut off during the float itself). Thus, when the
entry door to the float room was sealed and the blue LED light
inside the pool was turned off, the float room was completely
dark. Auditory stimulation was minimized by constructing
the float room using multiple layers of sound dampening
walls with thick insulation and added soundproofing material,
restricting most outside airborne sound from entering the
room. Structural sounds transmitted via vibrations in the floor
were minimized by having the float pool rest on a bed of 48
butyl rubber springs, effectively isolating the pool from the
building and preventing structure-borne noises from entering
the water. Olfactory stimulation was minimized by using only
unscented cleaning products and having the participant shower
beforehand to help remove body odors. In addition, the water
disinfection system used a combination of ultraviolet light and
35% hydrogen peroxide which does not emit any odors during
the oxidative process. Gustatory stimulation was minimized by

Frontiers in Neuroscience

FIGURE 1

Concurrent physiological measurement during Floatation-REST
(Reduced Environmental Stimulation Therapy). In order to
collect physiological data during the float session, small
non-invasive wireless sensors were attached to the participant.
To measure heart rate, breathing rate, and HRV, a Zephyr
BioPatch ECG system was attached to the chest with a layer of
waterproof Tegaderm. To measure blood pressure, a QardioArm
monitor was placed around the upper left arm with a waterproof
cast. We also collected electroencephalography (EEG) using a
wireless system that was placed on the forehead, in addition to
accelerometry using accelerometers attached to each wrist;
these data will be part of a separate publication. Of note,
participants floated without any clothing on. The same sensors
and setup were also used to collect physiological data during
the film condition.

having participants eat several hours before the float, while
refraining from eating and drinking during the float. Thermal
stimulation was minimized by setting the temperature of the
water and the air to closely match the temperature at the
surface of the skin, which is typically a few degrees cooler than
core body temperature. All temperature sensors were calibrated
using a Thermoworks precision thermometer (Utah, USA)
certified by the National Institute of Standards and Technology
(NIST). Throughout each float session, the water temperature
was maintained at 95.0◦ F (±0.3◦ F) and the air temperature
at the rim of the pool was maintained at 93.5◦ F (±0.5◦ F),
slightly lower than the water temperature based on the relative
humidity in the air. This temperature setting helped minimize
the need for thermoregulation while reducing the perceptual
boundary between air, body, and water. Specific gravity of the
water was calibrated using an H-B Instrument Polycarbonate
Hydrometer (Pennsylvania, USA) that was NIST calibrated to
achieve an accuracy within 0.002. The density of the water was
maintained at a specific gravity between 1.25 and 1.26 for all
float sessions. The body’s immersion in this dense saline solution
minimized stimulation from tactile, vestibular, gravitational,
and proprioceptive channels by buffering the body against the
forces of gravity and allowing the individual to effortlessly float
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on their back in a state of stillness. The importance of “stillness”
was also emphasized during the pre-float instruction set, further
helping to minimize both movement and speech.
All participants were instructed that they could float “for up
to 90 min” and could stop floating at any time. The following
script was read prior to the float session: “Throughout the
day, our brain and body are constantly bombarded by sensory
information from the external world. In this study, we aim to
understand what happens when you get a chance to disconnect
from this constant stimulation by floating in an environment
with reduced levels of light and sound, and reduced pressure
on the spinal cord. While floating, try to find a place of stillness
of both body and mind. You have complete control throughout
the experience and can stop at any time. During the float we
encourage you stay awake and when the float is over we will
turn on some music for you. There is no rush, so please take your
time exiting the pool.” No additional instructions were provided
for how participants should spend their time during the float
session. At the end of each float session (at ∼82 min), the song
“Relax” by Blank & Jones (Relax Edition One, 2005) was played
through the speakers, signaling to the participant that the float
session was almost over.

Self-report measures were administered ∼30 min before and
after completion of each condition, and across all measures
participants were asked to rate how they felt “right now, in the
present moment.” Pre- to post-float/film changes scores were
computed for each participant.

State-Trait Anxiety Inventory
The Spielberger State Anxiety Inventory (STAI) is a 20-item
self-report questionnaire that assesses an individual’s anxiety
at the present moment. Scores can range from 20 to 80 and
items assess for the presence or absence of current anxiety
symptoms. The STAI has excellent internal consistency and
good convergent and discriminant validity (Spielberger et al.,
1983).

Serenity scale
Participants also completed the serenity scale from the
Positive and Negative Affect Scale - Expanded Form (PANASX). The PANAS-X has high internal consistency, and good
convergent, discriminant, and construct validity (Watson and
Clark, 1999). Participants completed the PANAS-X serenity
scale using the “at the present moment” instructions. The scale is
comprised of three items: “How calm do you feel? How relaxed
do you feel? How at ease do you feel?”

Film condition
The physiological changes during Floatation-REST were
directly compared to an exteroceptive comparison condition
that took place at the same time of day as the float session. The
first 10 min entailed a baseline period during which participants
remained with their eyes open while looking at a fixation cross
on the screen. The remaining 80 min entailed watching three
episodes (Great Plains, Jungles, and Seasonal Forests) from the
BBC Planet Earth nature documentary series (2006) that were
edited into a single film clip. The film contained pleasant and
serene scenes of geographic landscapes and wildlife. Segments
that had the potential to elicit intense emotional or physiological
responses, such as depictions of violence or mating, were
intentionally excluded. The film was presented on a computer
monitor (21.5 × 15 inches) with speakers, and participants were
seated upright in a stationary chair approximately 30 inches
away from the monitor. The average room temperature during
the film condition was 72.3◦ F (±1.6◦ F). As in the FloatationREST condition, participants were encouraged to stay awake
during the film and to try to find a place of stillness in order
to minimize both movement and speech.

Physiological data collection
Physiological measurements were recorded during each
float and film session using a QardioArm blood pressure
unit and a Zephyr BioPatch electrocardiogram (ECG) system
(Figure 1). These devices were specifically chosen due to
their small size, wireless sensors, and low voltage batteries
which made the devices non-invasive and safe for use in
the float pool’s aqueous environment. Blood pressure was
measured using a QardioArm wireless monitor (Qardio Inc.,
San Francisco, California, USA) that is an FDA-approved
automated sphygmomanometer which uses the Oscillometric
method to achieve a measurement range of 40–250 mmHg and
an accuracy of ±3 mmHg. The QardioArm has been clinically
validated according to ANSI/AAMI/ISO 81060-2:2009 as well as
the European Society for Hypertension International Protocol
(O’Brien et al., 2010). The blood pressure cuff was positioned
approximately 1 inch above the elbow, around the left upper
arm, so that it was situated at the same level as the heart.
During both conditions, participants were instructed to keep
their arms positioned downward, resting along the side of their
body. A LimbO Waterproof Protector (Limbo USA, Portland,
Maine, USA) was placed over the QardioArm in order to prevent
water from reaching the QardioArm during the float session. To

Self-report measures
Participants completed all self-report measures on an Apple
iPad using REDCap (Research Electronic Data Capture).1

1

www.projectredcap.org
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ensure comparability across conditions, participants also wore
the LimbO during the control condition. All blood pressure
data were wirelessly transmitted in real-time via Bluetooth 4.0
to an iPad tablet located in the adjacent control room. Each
blood pressure measurement took 30–60 s to complete and
was initiated remotely by the experimenter using an application
on the iPad. Blood pressure measurements were collected once
every 10 min during the float and film conditions, with the first
3 measurements taken every 5 min in order to provide a higher
temporal resolution for any potential changes occurring toward
the beginning of a session. A small number of measurements
(<3% of the total blood pressure measurements) were missing
(due to a temporary loss in Bluetooth connectivity with the
QardioArm) or were excluded if the reading was deemed
an outlier based on previous guidelines that recommended
excluding all measurements greater than 2 standard deviations
from an individual’s average blood pressure during the float or
film session (Lee et al., 1995). In addition, blood pressure data
from one anxious participant was excluded due to a complete
loss in Bluetooth connectivity during the float session. This
left complete datasets from 56 participants (36 anxious and 20
non-anxious participants) where every participant had blood
pressure data successfully collected in both conditions.
The Zephyr BioPatch was used to record ECG, heart rate,
and breathing rate. The BioPatch is a CE-certified, FDAapproved Class II device that is water resistant up to 1 meter
(IP67) and powered by a 3.7 V rechargeable lithium-ion battery
(making it completely safe in the event that water did get
in). Through its FDA approval, the BioPatch was shown to be
equivalent to the Zephyr BioHarness 3.0, a predicate device. The
reliability and validity of the BioHarness has been established in
prior studies comparing the device to previously validated ECG
devices such as the 12-lead Schiller AG AT-110 (Rawstorn et al.,
2015). Zephyr Technologies has shown that the BioHarness 3.0
measures heart rate with a mean bias of 1.3 beats and SE of
0.29 beats as compared to Cortex BioPhysik MetaMax CPX 3
lead ECG system (Zephyr Technology, 2008). This was within
the study’s validation criteria of mean bias and a standard error
within 3 beats of the validated ECG system. In a review of ten
validation studies of the BioHarness, the device was reported
to have good construct validity with coefficients ranging from
0.74 to 0.99 when compared to gold standard devices (Nazari
et al., 2018). The BioPatch device used in this study contains the
same recording device, Zephyr BioModule, but is not secured
by a chest strap. While the Bioharness utilizes the chest strap
to monitor breathing rate, the BioPatch uses a proprietary
impedance-based metric (Zephyr Technology, 2012; Russell
et al., 2014). The BioPatch also contains a 3-axis accelerometer
which was used to establish the start time of each float based on
the moment of transition into a supine position.
The BioPatch uses a 2-lead ECG that is placed on the chest
above the sternum using adhesive electrodes. To protect the
device from water, it was covered with Tegaderm made by 3M, a
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transparent watertight medical dressing. Tegaderm also covered
the BioPatch during the film condition to ensure comparability.
Black electrical tape was used to cover a flashing LED light on the
BioPatch, removing this extra source of visual stimulation. All
data collected by the BioPatch in the film and float conditions
were stored locally on the device and then transmitted to a
computer after completion of the experiment. The BioPatch
recorded ECG at 1,000 Hz and calculated the average heart rate
and breathing rate at 1 Hz. The BioPatch also outputs heart rate
confidence values that account for the signal-to-noise ratio of
the ECG signal, with confidence values above 20% indicating
a reliable signal. All time points below 20% confidence were
excluded from the analysis (Zephyr Technology, 2016). If a
float or film session contained over 30 min of ECG data under
20% confidence, then the entire dataset was excluded; this
criterion ultimately led to the exclusion of 6 participants. In
addition, a small amount of individual datapoints (<1% of the
total BioPatch measurements) were excluded during manual
inspection of the ECG data as described in the subsequent
section.

Physiological metric calculation
All analyses utilized physiological data from the first 80 min
of the float and film session since music was played during
the final 10 min of the float session and some subjects exited
the pool before 90 min had elapsed. The average heart rate
and breathing rate were calculated over 5-min bins based on
the values outputted from the BioPatch each second. HRV
metrics were also binned into 5-min intervals and extracted
from time and frequency domains. Time domain metrics refer
to measurements that quantify the amount of variability in
the inter-beat interval, while frequency domain metrics explore
the power of discrete frequency components, as measured
via Fast Fourier Transformation or autoregressive modeling
of the ECG signal. Initial standards for these measurements
were developed by a task force in Malik et al. (1996). Among
the time domain metrics are the standard deviation of the
interbeat interval of normal sinus beats (SDNN), and the root
mean square of successive differences between normal beats
(RMSSD). The SDNN represents all of the cyclic components
that go into variability during a recording period, while the
RMSSD reflects changes in HRV that are vagally mediated
and largely independent of respiratory influences (Laborde
et al., 2017; Shaffer and Ginsberg, 2017). For time-domain
analyses, we extracted the SDNN and RMSSD. For frequencydomain analyses, the HRV metrics were estimated based on
the total and ratio power spectral densities within predefined
frequency bands. Welch’s procedure was used to estimate the
power spectral density from three frequency bands of interest
as follows: the very low frequency (VLF) band [0.003–0.04 Hz],
low frequency (LF) band [0.04–0.15 Hz], and high frequency
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as a continuous variable, or categorically). The analysis fitted
separate LMMs with different fixed-effects: main-effects only
and main-effects with all possible combinations of interaction
terms. All LMMs included random intercepts to account for
participant-specific variability. Bayesian information criterion
(BIC) was used to identify the optimal models. Secondly, we
evaluated the correlations between physiology and changes
in state anxiety and serenity using LMM; each physiological
measure was regressed on change scores of state anxiety and
serenity, condition, and their 2-way interaction, along with time
and group. All analysis was performed using RStudio version
1.0.136, using the R packages lme4 (version 1.1-19) for LMM and
the R package lmerTest (version 3.0-1) for calculation of degrees
of freedom and p-values based on the Kenward–Roger method.

(HF) band [0.15–0.4 Hz] (Ramshur, 2010). The measures of
spectral power are reported in terms of the absolute VLF (aVLF),
normalized LF (nLF), and normalized HF (nHF).
Electrocardiogram signals were first preprocessed using
traditional signal processing including smoothing, detrending
and scaling to achieve consistent and reliable peak detection.
In addition, ECG points corresponding to low heart rate
confidence intervals (<20% as the recommended threshold
for usable data based on the BioPatch manual) were excluded
from analysis prior to the peak detection phase. Due to the
length of sessions (80 min), conducting quality assurance checks
on the HRV data can be challenging. Thus, we designed
and implemented a customized semi-automatic QRS complex
detection algorithm in MATLAB to automatically annotate
detected peaks on long ECG recordings. When the algorithm
does not detect a peak within two seconds from the previous
peak, the time period is annotated for manual inspection
to determine where a peak occurs within the time frame.
Manual inspection of each individual’s annotated ECG signal
was conducted visually by research assistants to ensure the
quality of detected peaks and ensure the exclusion of abnormal
signals. The most prominent peaks outputted by the BioPatch
were either the R or S wave from the QRS complex. Each dataset
only had one prominent peak (either the R or S wave), thus, for
each dataset, either the R or S peak was selected to compute the
interbeat intervals (IBI) between detected peaks.
We utilized HRVAS (Ramshur, 2010), a Matlab-based HRV
software package that has been utilized in dozens of other peerreviewed papers to extract the aforementioned HRV metrics.
The IBI series was divided into non-overlapping 5-min windows
for each individual and processed by HRVAS to provide timedomain and frequency-domain analysis. Before calculating the
time-domain metrics, HRVAS performs an ectopic interval
detection and correction process to reduce analysis errors due
to abnormal heartbeats. The frequency domain analysis also
includes the same ectopic interval detection and correction
process, but also undergoes a detrending and an IBI resampling
process for the Welch periodogram analysis used here. These
additional processes were necessary to ensure the stationarity of
each IBI series as required by the power spectrum estimations
and helped remove low-frequency trends and ensure that the
series were regularly sampled.

Result
The anxious and non-anxious groups were closely matched
based on age and sex (Table 1). All participants in both groups
completed the float and film session. Most participants remained
floating for the entire 90-min duration, with the exception of
seven anxious and four non-anxious participants who exited the
pool shortly after the music signaling the end of the float session
started playing (∼85 min into the float). Thirteen anxious
and seven non-anxious participants floated with the lights off
throughout the entire session and the remaining participants all
floated with the lights off for the vast majority of the session
(80.5 min on average).
BIC selected models only containing the main effects of
group (anxious vs. non-anxious), condition (float vs film), and
linear time in predicting each individual cardiac metric. For
every metric, with the exception of breathing rate, the term
for group was not significant. As no significant effect of group
was found for any of the cardiac metrics, Figure 2 displays the
data for each condition collapsed across groups, with Table 2
reporting the overall means and effect sizes. The data broken
down by each group is displayed in Supplementary Figure 1.
Supplementary Figures 3, 4 show how many datasets were
excluded for each physiologic metric. The study was powered
to detect an f2 effect size of 0.133 at a power of 0.8 (Selya et al.,
2012). This is between a small and medium effect size (small:
f2 ≥ 0.02, medium: f2 ≥ 0.15, and large: f2 ≥ 0.35).
For heart rate, there was a non-significant trending effect
of condition (mean difference (diff): 0.4 beats per minute;
F (1 ,1486) = 3.20, p = 0.073) with lower heart rates in the
float condition, and a non-significant trending effect of time
(F (1 ,1486) = 3.42, p = 0.065) with a gradual increase in
heart rate over the course of both conditions. There were
significant differences between conditions for breathing rate
(diff: 0.76 breaths per minute; F (1 ,1485) = 42.5, p < 0.001) with
lower breathing rates in the float condition. There were also
significant breathing rate differences between groups (diff: 1.41

Statistical methods
All measures were analyzed by linear mixed-effects models
(LMMs). HRV measures (including nHF, nLF, aVLF, SDNN,
and RMSSD) were log transformed for use in parametric
testing and LMMs as none met the criteria for normality.
First, to assess the effects of floating on each physiological
measure, we considered 3 main-effects: condition (float vs. film),
group (anxious vs. non-anxious), and time (either presented
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FIGURE 2

Cardiovascular effects of Floatation-REST as compared to the film condition. Mean physiological response as broken down by condition
(blue = float; orange = film) across all participants for panel (A) heart rate, (B) systolic blood pressure, (C) diastolic blood pressure, (D) absolute
very low frequency HRV, (E) normalized low frequency HRV, (F) normalized high frequency HRV, (G) SDNN, (H) RMSSD, and (I) breathing rate.
The shaded region represents the standard error of the mean. The x-axis represents time (in minutes) since the start of the float or film. With the
exception of blood pressure (which were single point measurements), data are graphed in 5-min bins such that timepoint 0 is the average from
0 to 5 min, and timepoint 75 is the average from 75 to 80 min. Significant differences were found between conditions for all variables except
heart rate.

(F (1 ,1416 .0) = 24.6, p < 0.001), an increase in nLF over time
(F (1 ,1416 .0) = 24.2, p = 0.001), an increase in aVLF over time
(F (1 ,1413 .1) = 14.4, p = 0.001), an increase in SDNN over time
(F (1 ,1414 .0) = 5.20, p = 0.023), and a slight decrease in RMSSD
over time (F (1 ,1416 .0) = 4.00, p = 0.046).
In the second phase of analysis, we examined the
relationship between physiology and changes in state anxiety
and serenity. As compared to the film condition, FloatationREST induced higher levels of serenity (F (1 ,52 .1) = 22.8,
p < 0.001) and lower levels of state anxiety (F (1 ,110 .0) = 7.50,
p = 0.007) across both groups (Figure 3); neither model
contained significant group by condition effects. There were
significant interactions between changes in state anxiety
and condition for systolic blood pressure (F (1 ,947 .3) = 11.0,
p = 0.001), diastolic blood pressure (F (1 ,947 .9) = 15.4, p < 0.001),
and heart rate (F (1 ,1482 .9) = 21.4, p < 0.001). Simple slope
analysis for the interaction predicting systolic blood pressure
revealed a significant positive slope for the float condition
(slope = 0.25, p < 0.001), and a non-significant slope for the

breaths per minute; F (1 ,46 .0) = 4.49, p = 0.039), with higher
breathing rates found among anxious participants in both
conditions, as well as significant breathing rate differences over
time (F (1 ,1485) = 6.86, p = 0.009), with breathing rates increasing
over the course of both conditions. For blood pressure, there
were significant effects of condition for both systolic blood
pressure (diff: 3.40 mm Hg; F (1 ,944) = 42.5, p < 0.001), and
diastolic blood pressure (diff: 8.54 mm HG; F (1 ,945) = 598.3,
p < 0.001), indicating lower blood pressure in the float condition
as compared to the film condition.
In terms of HRV, all metrics showed significant effects of
condition when comparing the float to the film. This included
increased nHF (diff: 0.06; F (1 ,1416 .1) = 100.2, p < 0.001),
decreased nLF (diff: 0.06; F (1 ,1416 .1) = 102.8, p < 0.001),
decreased aVLF (diff: 1305.0; F (1 ,1413 .2) = 349.7, p < 0.001),
decreased SDNN (diff: 13.1; F (1 ,1414 .1) = 198.5, p < 0.001), and
decreased RMSSD (diff: 1.07; F (1 ,1416 .0) = 4.08, p = 0.043). Each
metric also showed significant effects of time in both conditions
(measured continuously), including a decrease in nHF over time
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TABLE 2 Mean (SD) and between-condition effect sizes for each
physiologic metric.

Float

Film

Cohen’s d

Heart rate

70.01 (9.88)

70.41 (9.62)

0.04

Breathing rate

12.52 (3.14)

13.28 (3.27)

0.27

SDNN

52.85 (23.02)

65.92 (29.17)

0.59

RMSSD

34.42 (20.51)

35.49 (19.96)

0.05

0.33 (0.16)

0.28 (0.14)

0.49

nHF
nLF

0.67 (0.16)

0.73 (0.14)

0.49

aHF

608.46 (774.44)

548.06 (632.41)

0.09

aLF

1078.04 (1168.07)

1339.68 (1228.68)

0.28

aVLF

1126.95 (1168.07)

2431.97 (2452.27)

0.97

Systolic BP

114.91 (15.73)

118.31 (15.26)

0.22

Diastolic BP

66.76 (11.32)

75.30 (10.70)

0.84

FIGURE 4

Significant interactions between blood pressure and change in
state anxiety and serenity. Each point represents a single blood
pressure measurement for one participant, and each trend line
shows the correlation between blood pressure and change in
state anxiety and serenity broken down for each condition
(orange = film; blue = float). Significant interactions (p < 0.001)
were found between (A) state anxiety change and systolic blood
pressure, (B) serenity change and systolic blood pressure, (C)
state anxiety change and diastolic blood pressure, and (D)
serenity change and diastolic blood pressure.

FIGURE 3

Mean change in state anxiety and serenity. Mean change scores
from pre- to post-float/film were computed for each group and
condition (orange = film; blue = float) for panel (A) state anxiety,
and (B) serenity. Error bars represent the standard error of the
mean.

Interactions between changes in serenity and condition were
found for breathing rate (F (1 ,1512 .4) = 13.5, p < 0.001), systolic
blood pressure (F (1 ,949 .4) = 20.7, p < 0.001), and diastolic blood
pressure (F (1 ,950 .0) = 27.7, p < 0.001). Simple slope analysis
for the interaction predicting breathing rate identified a positive
slope for the film condition (slope = 0.10, p = 0.019), and a more
strongly positive slope for the float condition (slope = 0.305,
p < 0.001). This indicates a counterintuitive relationship, such
that greater increases in serenity were associated with higher
breathing rates in both conditions (Supplementary Figure 2).
Simple slope analysis for the interaction predicting systolic
blood pressure revealed a significant negative slope for the float
condition (slope = −1.12, p < 0.001) and a non-significant
slope for the film condition (slope = 0.02, p = 0.906). Simple
slope analysis for the interaction predicting diastolic blood
pressure revealed a similar pattern, with a significant negative
slope for the float condition (slope = −0.73, p < 0.001), and
a non-significant slope for the film condition (slope = 0.19,
p = 0.139). Both models for measures of blood pressure indicate
that individuals who increased the most in serenity over the

film condition (slope = 0.02, p = 0.711), indicating that in
the float condition, but not film condition, individuals who
decreased in state anxiety tended to have lower systolic blood
pressure (Figure 4). Simple slope analysis for the interaction
predicting diastolic blood pressure revealed a significant positive
slope for the float condition (slope = 0.10, p = 0.006) and a
significant negative slope for the film condition (slope = −0.09,
p = 0.010). This indicates that in the float condition, individuals
who decreased in state anxiety tended to have lower diastolic
blood pressure, but that this relationship was slightly reversed
in the film condition (Figure 4). Simple slope analysis for the
interaction predicting heart rate identified a significant positive
slope for the film condition (slope = 0.16, p < 0.001), but a nonsignificant slope for the float condition (slope = 0.01, p = 0.788).
This indicates that in the film condition, but not float condition,
individuals who decreased in state anxiety tended to have lower
heart rates during the condition (Supplementary Figure 2).
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course of the float tended to have lower systolic and diastolic
blood pressure during their float session (Figure 4).

leading to elevated sympathetic activity resulting in increased
heart rate, vasoconstriction, and an increase in blood pressure.
When viewing ANS activity in the frequency domain, it was
initially identified that the sympathetic output of the baroreflex
corresponds to the “10-s rhythm” in humans (DeBoer et al.,
1987), or the ∼0.1 Hz “Mayer wave” (Julien, 2006). Thus,
the power of the 0.1 Hz band, which lies squarely in the LF
band range, is presumed to primarily reflect the sympathetic
activation component of the baroreflex, particularly at rest
(McCraty and Shaffer, 2015). The current study’s finding of a
significant decrease in nLF during Floatation-REST provides
evidence supporting the notion that there was a decrease in
sympathetic output from the baroreflex, which aligns well with
the significant decrease in blood pressure observed during the
float condition.
Somewhat complementary to the baroreflex is the RSA
and the impact of breathing on HRV. As the name implies,
this process is primarily related to respiration, leading to an
elevation of heart rate during inspiration, and a reduction of
heart rate during expiration (Berntson et al., 1993; Yasuma
and Hayano, 2004). This process is driven by slowly adapting
pulmonary stretch receptors localized to the tracheobronchial
tree in the lungs (Schelegle, 2003). Excitation of slowly adapting
pulmonary stretch receptors during inspiration sends signals
through the vagus nerve to the NST, which then inhibits activity
in the nucleus ambiguous, decreasing vagal output and resulting
in a speeding up of the heart rate. The opposite is true in the case
of expiration, with vagal output increasing, resulting in a slowing
down of the heart rate. Because of this, the RSA is primarily
a reflection of vagal variability, or vagal tone. Because vagal
innervation of the heart’s pacemaker only involves two synapses
after exiting the brainstem, as compared to three synapses for
nerves of the sympathetic nervous system, this quicker activity is
reflected primarily in the HF band of HRV, which is also referred
to as the respiratory band for this reason (Shaffer and Ginsberg,
2017). While HF reflects the strength of this vagal component,
its variation is reflected in RMSSD of the time domain. The
current study’s finding of elevated nHF during Floatation-REST
suggests increased vagal modulation, potentially due to the
slower breathing observed during the float condition. This is
consistent with the biological behavioral model that highlights
the influence of breathing on vagal tone (Grossman and
Taylor, 2007). Even though Floatation-REST involves placing an
individual in an environment with reduced metabolic demand,
mean breathing rates while floating remained within a normal
range of approximately 12 breaths/min and only lowered an
average of less than 1 breath/min as compared to the film
condition. A complete understanding of the impact of breathing
on vagal tone was limited by the omission of measuring tidal
volume. Future studies may benefit from including this metric,
as breathing rate and tidal volume produce independent and
interactive effects (Hirsch and Bishop, 1981), and anxiety has
been associated with increased respiration rate and decreased

Discussion
This was the first study to investigate the cardiovascular
and respiratory-related effects during Floatation-REST, an
intervention which minimizes external sensory stimulation
of the human nervous system. Using a randomized withinsubjects crossover design, a combined cohort of 57 participants
underwent a 90-min float session and watched a 90-min
nature film. Relative to the film condition, Floatation-REST
significantly lowered both diastolic and systolic blood pressure,
as well as breathing rate. Heart rate showed a non-significant
trend of being lower during the float condition, especially during
the early phase of the float session. In the time domain of
HRV, Floatation-REST resulted in a moderate decrease in SDNN
and a smaller decrease in RMSSD. In the frequency domain of
HRV, Floatation-REST increased nHF and decreased nLF and
aVLF. Most of the physiological changes occurred within the
first 15 min of the float, and often persisted for the remainder
of the session (Figure 2). The effect sizes for the physiological
changes were in the small to medium range, except for the
reductions in diastolic blood pressure and aVLF, which were
both large effects (Table 2). Notably, we did not observe any
significant physiological differences between anxious and nonanxious comparison participants, save for the fact that the
anxious participants had a higher breathing rate across both
conditions. Overall, these results are generally consistent with
Floatation-REST inducing lower sympathetic output and higher
parasympathetic modulation but yield to a more dynamic and
nuanced interpretation when viewed in the wider context of
the intricate circuitry that serves to balance the ANS, including
the influence of the baroreflex and respiratory sinus arrhythmia
(RSA), which we discuss in more detail below.
The baroreflex is a feedback system that maintains blood
pressure homeostasis. Mechanoreceptors present in the aortic
and carotid sinuses respond to blood pressure, increasing firing
rates in response to increased pressure and hypertension (Taylor
et al., 2014; Ghitani and Chesler, 2019; Min et al., 2019). This
signal, carried through either cranial nerve IX (glossopharyngeal
nerve) or X (vagus nerve), synapses onto the nucleus of the
solitary tract (NST) in the brainstem (Pilowsky and Goodchild,
2002). Activation of the NST both decreases sympathetic activity
through brainstem projections to the intermediolateral nucleus
of the spinal cord and increases vagal outflow. This in turn
leads to a withdrawal of sympathetic activation from the heart’s
pacemaker, from myocardial cells, and from vascular smooth
muscle tissue. This results in a decrease in blood pressure
due to decreased heart rate and vasodilation, allowing for a
return to homeostasis. The opposite is also true, but in reverse.
Hypotension leads to decreased activation of baroreceptors,
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tidal volume in the lab (Gorman et al., 1988; Schwartz et al.,
1996).
The responsiveness of HRV in the frequency domain as
well as blood pressure can clearly be seen in the context of
relaxation. For example, a variety of relaxation techniques have
been connected to increases in HF-HRV and decreases in blood
pressure (Benson et al., 1975; Terathongkum and Pickler, 2004).
Similar to Floatation-REST, inwardly focused meditation has
resulted in a decrease in LF-HRV and an increase in HF-HRV
(Wu and Lo, 2008). A comparable pattern of HRV results
was also found in a meta-analysis looking at the physiological
effects of Tai Chi and Yoga (Zou et al., 2018). This aligns with
the neurovisceral integration model, which was developed to
help explain the interaction between peripheral cardiovascular
physiology and cognitive function in relation to health outcomes
(Smith et al., 2017). Because neural regulation of the heart
involves so many different levels of integration, the heart’s
behavior acts as a metric for health across levels, in everything
from autonomic functioning to mental health.
With this added context, it may be possible to consider
the frequency domain results as representative of a relaxation
response. Elevation of nHF likely reflects increased vagal
modulation as part of the RSA, which may be related to the
non-significant decrease in heart rate found during the early
part of the float session as well as the significantly decreased
breathing rate found throughout the float session (though as
a counterpoint, the decreased breathing rate observed during
Floatation-REST is not nearly as low as the slow-paced breathing
typically used to measure this effect in other experiments, e.g.,
Kapidžić et al., 2014 and Kromenacker et al., 2018). Decreases
in nLF likely reflect reduced Mayer wave activity, and thus
reduced baroreflex activity resulting in lower blood pressure.
This may, in part, reflect prefrontal inhibition of sympathetic
output normally coming from baroreflex activity (Julien, 2006;
McCraty and Shaffer, 2015). While the significantly lower
aVLF observed during Floatation-REST showed a large effect
size, there is currently no consensus on a straightforward
interpretation of this component. Some have suggested that
it is related to parasympathetic activity and thermoregulatory
vasomotor control (Fleisher et al., 1996) which would align with
our findings, but more investigation is needed (Kleiger et al.,
2005). Of note, the present frequency domain results, and the
initial study hypotheses, would suggest a larger decrease in heart
rate than what was found. However, this result could also reflect
other compensatory mechanisms at play in maintaining heart
rate in the face of the decreased blood pressure found during
Floatation-REST. Interestingly, visual inspection of the heart
rate plot (Figure 2) showed a dip in heart rate during the first
15 min that then returned to normal levels, indicating that such
compensatory mechanisms could be relatively fast acting.
The HRV results in the time domain were somewhat
unexpected, with both SDNN and RMSSD found to be
significantly lower during Floatation-REST. SDNN reflects all
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the cyclic components responsible for variability in the period
of recording, and RMSSD is a reflection of vagal tone, or
the responsiveness of the vagus nerve signal to changing
energetic needs from the environment that is mostly free of
respiratory effects (Laborde et al., 2017). Other relaxationbased interventions have found increases in SDNN and RMSSD
(e.g., Vinay et al., 2016). However, there are several differences
between typical measures of time-based HRV and the current
study. Firstly, this experiment measured cardiorespiratory
activity continuously during the float session, rather than in a
pre/post design. Leveraging the use of wireless and waterproof
technology provided real-time estimates of psychophysiological
activity and captured any regulatory adjustment to the float
environment. Secondly, Floatation-REST reduces all external
stimulation to an absolute minimum. Because of this, there is
very little exteroceptive sensory information to trigger a varied
autonomic response. Thus, it is possible that these experimental
results speak to higher vagal modulation, as measured by
elevated nHF and lower nLF, but a lack of variation within that
response, as indicated by reduced SDNN and RMSSD, due to
the fact that there were no external stimuli to respond to during
Floatation-REST.
While the current study did not find any interactions
between HRV metrics in either the time or frequency domain
and changes in anxiety, there were significant interactions
between blood pressure and changes in both state anxiety and
serenity. In each case, individuals with lower blood pressure
during floatation showed the greatest decreases in state anxiety
and the greatest increases in serenity, while this association
was not found in the film condition. This suggests that the
blood pressure reductions found during Floatation-REST may
be playing an important role in the anxiolytic effect. Other
interaction results were more perplexing. For example, there
was a positive relationship between anxiety change and heart
rate for the film condition, but no significant relationship for
the float condition. During the film, individuals who showed the
largest decrease in state anxiety tended to have lower heart rates
while watching the film. The lack of a significant relationship
during the float condition is unexpected but may align with
the abovementioned hypothesis that another compensatory
mechanism is maintaining a normal heart rate during floatation.
Alternatively, it is possible that the magnitude of the small dip
in heart rate during the first 15 min of floatation may be related
to changes in state anxiety, but as the model described above
considers heart rate over the entire course of floatation it may
miss this relationship. The interaction between serenity and
breathing rate is also counterintuitive but may have a simple
explanation. On the surface, it would seem that individuals with
higher breathing rates over the course of floatation had the
largest increase in serenity, which would be contrary to the view
that lower breathing rates are associated with relaxation (Chen
et al., 2017). However, a closer examination reveals that anxious
participants had higher breathing rates overall as compared to
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non-anxious comparison participants; thus, higher breathing
rates may act as a stand-in for anxious participants in this model.
In other words, the individuals who showed the greatest increase
in serenity following floatation were anxious participants, who
naturally had higher breathing rates.
Drawing these results together, frequency domain HRV data
from this experiment suggest that Floatation-REST results in
a shift to higher vagal modulation via decreased sympathetic
arousal, particularly in the sympathetic output from the
baroreflex. The concomitant reductions in blood pressure and
breathing rate may be related to the above changes, and this
pattern of decreased sympathetic arousal is in line with prior
studies showing a significant post-float decrease in circulating
levels of norepinephrine (Kjellgren et al., 2001; Caldwell et al.,
2022). However, the lack of significant heart rate changes paired
with the moderate decrease in SDNN and small decrease in
RMSSD highlight that any increase in vagal activity was limited
by a compensatory process that reduced the overall variability
between heartbeats and allowed the heart rate to be maintained
at a normal speed.
There are several important differences between the float
and film condition that must be addressed to fully contextualize
these findings. Body position between the two conditions was
not equivalent, with participants lying supine in the float
condition, but seated upright while viewing the film. Prior
studies directly comparing blood pressure while supine versus
sitting have found contradictory results, with some studies
showing lower blood pressure while supine (Netea et al., 1998;
Cicolini et al., 2011) and other studies actually showing higher
blood pressure while supine (Netea et al., 2003; Sala et al.,
2005; Eşer et al., 2007). Likewise, at least one study found
that frequency-based metrics of HRV, including both LF and
HF, were elevated when participants were resting supine, as
compared to seated or standing positions, which is the opposite
of our findings (Young and Leicht, 2011). In addition to changes
induced by postural differences, ambient air temperature should
be taken into account, as the air temperature in the float
condition was much warmer than the film condition. A previous
study showed a significant reduction in systolic (but not
diastolic) blood pressure when sitting in a room heated to
95◦ F (Sollers et al., 2002); however, this same study also found
increased heart rate, increased LF, and decreased HF which is the
opposite of our findings. Another potential explanation for the
reduction in blood pressure during Floatation-REST could be
related to vasodilation caused by the warm 95◦ F water. Upright
immersion into 97◦ F water has been found to reduce blood
pressure and increase HF-HRV (Miwa et al., 1997; Becker et al.,
2009; Hildenbrand et al., 2010), with another study showing a
similar pattern during supine floating (Nishimura and Onodera,
2001). Thus, some of the cardiovascular changes found in the
present study could be due to simply being immersed in warm
water. However, the salinity of the water used in this experiment
might not be related to the observed decrease in blood pressure,

Frontiers in Neuroscience

as at least one previous study found that immersion in highly
saline water (from the Dead Sea) led to an increase in blood
pressure as compared to freshwater immersion (Ish-Shalom and
Better, 1984). Future float studies exploring the cardiovascular
changes induced by Floatation-REST should consider more
active comparator conditions that entail laying supine, including
perhaps in a shallow pool of 95◦ F water but without the Epsom
salt. Such comparisons could help to clarify whether the effects
reported here are related to the supine body position, immersion
in warm water, or immersion in supersaturated saltwater.
There are several additional limitations to the current study.
While rigorous quality control checks of the physiological data
were undertaken, the wireless devices that we used are relatively
new and have only been validated in a few prior studies
(as outlined above under physiological data collection). The
breathing rate data provided by the BioPatch used a proprietary
algorithm based on impedance that may not be completely
comparable to the stretch-based sensors that are traditionally
used for measuring respiratory rate. The additional procedures
undertaken to waterproof the physiological equipment may
have possibly introduced added variability into the data,
although the same procedures were also used during the film
condition to ensure comparability of results. Another important
limitation is that the study’s sample size was underpowered to
identify small HRV effect sizes, and this should be considered
when interpreting the results (Laborde et al., 2017; Shaffer
and Ginsberg, 2017). While it is conceivable that there would
be differences in the physiological response between anxious
and non-anxious participants (e.g., Chalmers et al., 2014), the
study was likely underpowered to identify such differences.
Nevertheless, the findings suggest that floating may induce a
similar pattern of physiological change irrespective of anxiety
level.
The ability to collect physiological measures during
Floatation-REST opens a path to a variety of exciting future
directions. First and foremost, a replication of these findings is
warranted using a more active comparison condition in order to
better understand whether the pattern of cardiovascular changes
found in this study represent the default state of the ANS
when external stimulation of the CNS is minimized. Moreover,
physiological measurements should be acquired before each
condition in order to ensure that any differences between
conditions are not being driven by baseline differences, which is
another limitation of the current study. It will also be important
to gain a better understanding of how long the cardiovascular
effects last after a float session is over in order to inform the
design of future longitudinal float studies. For example, the
significant decreases in blood pressure raise the possibility of
testing participants with hypertension to examine the longevity
of floating’s hypotensive effects (Fine and Turner, 1982). Future
experiments could also pair Floatation-REST with reactionary
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stress experiments to provide insight into how floatation
might buffer the body’s response to stress, including stressrelated effects on HRV (Levine et al., 2016). The results and
methodology presented here provide an important foundation
for these future investigations into Floatation-REST.
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